COFIDES invests €11 million in Anaconda Biomed to boost stroke technology
COFIDES is investing 11 million euros in Anaconda Biomed as part of a 49 million euro Series E round. The deal aims to boost a technology against stroke. The State is among the company's shareholders, according to the published information.
Read the full story at webcapitalriesgo.com
IASummary generated by artificial intelligence from a story by webcapitalriesgo.com. It may contain errors: the original source prevails.
